Healthcare AI Acquisition, a blank check company formed by Stanley Capital targeting the healthcare and pharma sectors, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50.
The company is led by CEO and Chairman Simon Cottle and CFO and Director Patrick Hargutt, who are Founding Partners of Stanley Capital, an independent investment firm focused on healthcare, technology, and resource efficiency. The company plans to target businesses in the healthcare and pharmaceutical sectors with technological transformation potential.
Healthcare AI Acquisition plans to list on the Nasdaq under the symbol HAIAU. Citi and Jefferies acted as joint bookrunners on the deal.